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ABSTRACT
Misfolded proteins are caused by genomic muta-
tions, aberrant splicing events, translation errors
or environmental factors. The accumulation of
misfolded proteins is a phenomenon connected to
several human disorders, and is managed by stress
responses specific to the cellular compartments
being affected. In wild-type cells these mechanisms
of stress response can be experimentally induced by
expressing recombinant misfolded proteins or by
incubating cells with large concentrations of amino
acid analogues. Here, we report a novel approach for
the induction of stress responses to protein aggre-
gation. Our method is based on engineered transfer
RNAs that can be expressed in cells or tissues, where
they actively integrate in the translation machinery
causing general proteome substitutions. This
strategy allows for the introduction of mutations of
increasing severity randomly in the proteome,
without exposing cells to unnatural compounds.
Here, we show that this approach can be used for
the differential activation of the stress response in
the Endoplasmic Reticulum (ER). As an example of
the applications of this method, we have applied it to
the identification of human microRNAs activated or
repressed during unfolded protein stress.
INTRODUCTION
Quality control of the proteome begins during protein
synthesis (1–3) and ends with stress responses that
manage misfolded proteins throughout the cell (4,5).
Accumulation of misfolded proteins in the lumen of the
endoplasmic reticulum is managed by the unfolded protein
response (UPR) (6) and unfolded polypeptides in the
cytosol induce the heat-shock response (7,8).
Unrecoverable misfolded proteins in diﬀerent cellular com-
partments are tagged for degradation by the ubiquitin–
proteasome system (UPS) (9,10). In addition to the UPR
and the UPS, a third unfolded protein response has been
described in the mitochondria (11–13). A detailed under-
standing of the coordination among proteome quality
control mechanisms, and of relative hierarchies among
existing stress control pathways, is lacking.
Typically, stress responses to the accumulation of
unfolded proteins have been studied via two diﬀerent
experimental strategies: the utilization of single mutant
proteins known to aggregate, or the incubation of
cells with analogues of proteinogenic amino acids.
Historically, the use of amino acid analogues like azetidine
carboxylic acid or canavanine has been extremely useful
for the identiﬁcation of components of the heat-shock
response and the UPS (14,15). Canavanine and ACA
cause cell toxicity in a large number of experimental
systems. These toxic eﬀects are generally attributed to
their ability to inﬁltrate the proteome, although the incu-
bation of cells with amino acid analogues probably can
aﬀect other cellular pathways.
Generally speaking unfolded protein accumulation in
the Endoplasmic Reticulum (ER) causes the release of
the ER-resident chaperone Grp78 (BiP) from its
membrane localization (16). Release of BiP induces three
adaptive responses that require activation of Xbp-1,
phosphorylation of eIF2a and proteolytic cleavage of
ATF6 (16,17). If adaptive responses fail to reduce ER
stress pro-apoptotic pathways are induced through
the activation of the transcription factor CHOP.
The mechanisms that control the necessary balance
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between adaptive and pro-apoptotic responses are still
poorly understood (18–20).
Studies of the UPR, or of the ER-associated protein
degradation pathway (ERAD), typically rely on protein
mutants that are aberrantly glycosylated in the ER and
are thus targeted for degradation by the proteasome. An
example of such a protein is human a1-antitrypsin variant
null Hong Kong (21). Studies of the UPR-ERAD
pathways have revealed the extraordinary complexity of
the glycosylation machinery of the ER, and the
co-existence of parallel stress mechanisms that respond
to diﬀerent glycosylation signals (16,22–25). Thus, the
use of single protein markers, albeit extremely informa-
tive, may not be enough to activate the whole set of
UPR-ERAD components and interactions.
In this work, we present a new approach to generating
proteome errors and unfolded protein stress in cells. We
have engineered a battery of mutagenic tRNAs that intro-
duce a range of 10 diﬀerent mutations in a human cell type
and in a vertebrate embryonic model. In order to quickly
follow the eﬀect of each tRNA, we have constructed a
GFP protein that is not aﬀected by the mutagenic
tRNAs and can be used as a marker of the overall phys-
iological state of the cells. This method allows for the
controlled induction of generalized proteome defects in a
direct manner, without the potential for other secondary
eﬀects. This strategy also permits the uniform introduc-
tion of diﬀerent types of mutations throughout the
proteome, which can be applied to the analysis of the
timing and grade of diﬀerent stress responses, as well as
to the identiﬁcation of new links between those responses.
Here, we show that these mutagenic tRNAs eﬃciently
and speciﬁcally cause randomized proteome mutations
and increasing levels of stress response activation
depending on the mutation being introduced. As an
example, we describe the utilization of this method for
the identiﬁcation of human microRNAs (miRNAs) that
may be involved in the induction of apoptosis during late
stages of the unfolded protein response.
MATERIALS AND METHODS
Construction of tRNA chimeras
A DNA fragment of 0.7 kb corresponding to the gene
encoding human wild-type tRNASer and its ﬂanking
regions was ampliﬁed by PCR from genomic DNA and
cloned into vector pCR2.1. Chimeras of tRNASer were
built by QuikChange site-directed mutagenesis from
Stratagene by substituting the anticodon wild type by 18
other nucleotide triplets (to amber stop codon UAG or 17
diﬀerent anticodons, Supplementary Table S1). Similarly,
QuikChange site-directed mutagenesis was used to
replace codon 65 in GFP by 18 other nucleotide triplets.
To restrict the decoding speciﬁcity of the chimeras to
codon 65, we took advantage of the degeneracy of the
genetic code and chose anticodon/codon combinations
that were unique and not represented elsewhere
within the sequence of the GFP. Since methionine and
tryptophan are encoded by a single codon, these two
chimeras were purposely removed from our study.
Amino acids quantitative analysis
Samples were hydrolysed in 6M HCl for 16 h at 110C
and ﬁltered. Excess HCl was evaporated to complete
dryness and the pellet was resuspended in 20mM HCl.
Filtered samples were derivatized using AccQ-Tag
(Waters) (26,27), and derivatized amino acids were
quantiﬁed by HPLC (WATERS600, Waters) [UV detec-
tion =254 nm, detector W-2487 (Waters)].
Cell culture
Hek293 cells were grown in DMEM with 10% fetal
bovine serum (FBS), 100U/ml penicillin, an 100mg/ml
streptomycin at 37C, 5% CO2. For transient
transfections cells (60–70% conﬂuence) were transfected
with 10 mg DNA/ml using lipofectamine (Invitrogen), fol-
lowing the manufacturer’s instructions.
Chick in ovo electroporation
Eggs from White-Leghorn chickens were incubated at
38.5C in an atmosphere of 70% humidity. Embryos
were staged according to Hamburger and Hamilton (28).
Chick embryos were co-electroporated with plasmids
encoding chimeric tRNAs together with GFP. Brieﬂy,
plasmid DNA was injected into the lumen of HH Stage
11–12 neural tubes, electrodes were placed either side of
the neural tube and electroporation carried out using an
Intracel Dual Pulse (TSS10) electroporator delivering ﬁve
50ms square pulses of 30–40V. Transfected embryos were
allowed to develop to the speciﬁc stages, then dissected,
ﬁxed and processed for immunohistochemistry or in situ
hybridization. One hour prior ﬁxation BrdU was injected
into the lumen of neural tubes.
Metabolic labelling
Four hours after transfection with the plasmids encoding
the chimeras, Hek293 cells were pulsed with L-
azidohomoalanine 200 mM (methionine’s analogue) for
1 h in DMEM without methionine (Invitrogen). Cells
were lysed and labelled with the Click-iT Protein
Analysis Detection kit (Invitrogen). Labelled proteins
were loaded on a 10% denaturing polyachrylamide gel
and visualized by UV.
Cell proliferation and cell death
Cells were incubated in 96-well plate with 10 ml of WST-1
(Roche). The formazan dye produced by metabolically
active cells was quantiﬁed by a scanning multiwell
spectrophotometer at 450 nm after 1 h WST-1 addition.
For quantiﬁcation of cell death, cells were grown in
96-well plate and incubated with 5 mg/ml of propidium
iodide (Sigma Aldrich), and measured by ﬂow cytometry.
Statistical analysis
The list of ER proteins was obtained from the HERA
database (http://www.mcb.mcgill.ca/hera/). Lists of
proteins from the cytoplasm, mitochondria and
nucleus families were obtained from the Gene Ontology
project Consortium (2000) (2 July 2008 release), using
the following GO identiﬁers: GO:0044428, GO:0005739,
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GO:0044444, respectively. To count codon frequencies, we
used the CCDS database (2 July 2008 release, http://www
.ncbi.nlm.nih.gov/ccds/), which provides the nucleotide
sequences for human proteins. Finally, the protein
family lists were mapped to the CCDS database using
NCBI RefSeq identiﬁers. To assess the eﬀect of several
factors on ﬂuorescence, we used general additive models,
as implemented in the gam function in the R package
mgcv S.N. (2004)17. The smoothing parameters were set
via cross-validation. The threshold for statistical signiﬁ-
cance was 0.05.
RT–PCR analysis of XBP-1 splicing
Total RNA from Hek293 cells was extracted using Trizol
reagent (Invitrogen) and treated with DNase 30min at
room temperature to remove traces of genomic DNA.
RNAs were puriﬁed on RNAeasy columns (Qiagen)
before being reverse transcribed using the Reverse
Transcription System (Promega). cDNA was used as a
template for PCR ampliﬁcation across the fragment of
the Xbp-1 cDNA bearing the intron target of IRE1a
ribonuclease activity. Primer and PCR conditions used
were those described by Lin et al. (19). A 289 base pair
amplicon was generated form unspliced Xbp-1; a 263 base
pair amplicon was generated from spliced Xbp-1. PCR
products were resolved on a 2% agarose/0.5X TBE gel.
Semi-quantitative RT–PCR analysis
Total RNA was collected and cDNA retro-transcribed as
described above. Primers used to amplify BiP, Chop and
Rpl19 cDNA are those described by Lin and collaborators
(19). Rpl19 mRNA encodes a ribosomal protein, whose
transcription is not regulated by ER stress. It served as
a marker of equal loading. PCR conditions for these
three species were: 1 95C for 1min; 23 95C for
1min, 55C for 1min, 72C for 1min 30 s. Primers to
amplify GFP cDNA are: 50-CCACCTACGGCAAGCT
GACC-30 and 50-TGCTGGTAGTGGTCGGCGAG-30.
PCR conditions were: 1 95C for 1min; 23 95C for
30 s, 60C for 1min, 72C for 1min 30 s.
Western blot analysis
Hek293 cells were placed in cold lysis buﬀer (300mM
NaCl, 20mM Tris, 10mM EDTA, 2% Nonidet NP-40,
plus protease inhibitors), scraped and centrifuged. Fifty to
sixty mg of total cell lysate were separated by 10% SDS–
PAGE and transferred to Immobilon-P (Millipore),
followed by incubation with primary antibodies and the
appropriate peroxidase-conjugated secondary antibodies
and ECL detection (Pierce). Anti-phospho-eIF2a
was from Invitrogen; anti-ATF-4 was from Aﬃnity
BioReagents; anti-GFP was from Immunokontact (IK);
anti-b-tubulin was from Chemicon; monoclonal
anti-Ubiquitin was from Biomol; anti-ATF-6 and
polyclonal anti-Hsp72 were from Stressgen.
Immunohistochemistry and in situ hybridization
For immunostainings, chicken embryos were ﬁxed 2–4 h at
4C in 4% paraformaldehyde in PB, rinsed, and sectioned
in a Leica vibratome (VT 1000S). Immunostainings
were performed following standard procedures. For
bromo-desoxy-uridine (BrdU) detection, sections were
incubated in 2N HCl for 30min followed by 0.1M
Na2B4O7 pH 8.5 rinses further PBT rinses and
anti-BrdU incubation. The following antibodies were
used: anti-green ﬂuorescence protein (GFP) (Molecular
Probes), anti-caspase3 (BD) and anti-BrdU (G3G4 from
the Developmental Studies Hybridoma Bank). Alexa488-
and Alexa555-conjugated anti-mouse or anti-rabbit
antibodies (Molecular Probes) were used. After single or
double staining, sections were mounted, and imaged using
a Leica confocal microscope. Cell counting were done on
10–40 diﬀerent sections of at least four diﬀerent embryos
after each experimental condition (n> 4). For in situ
hybridization, embryos were ﬁxed overnight at 4C in
4% paraformaldehyde in PB, rinsed and processed for
whole mount RNA in situ hybridization following
standard procedures using probes for chick BIP (form
the chicken EST project, UK-HGMP RC).
Hybridization was revealed by alkaline phosphatase-
coupled anti-digoxigenin Fab fragments (Boehringer
Mannheim). Hybridized embryos were post-ﬁxed in
4% paraformaldehyde, rinsed in PBT and vibratome
sectioned.
Analysis of variations in microRNA populations caused
by mutagenic tRNAs
Total RNA was isolated from Hek293 cells 48 h upon
transfection with chimeric tRNAs. Five micrograms of
labelled RNA from each treatment was hybridized to a
microRNA microarray with 866 human miRNAs
(Agilent Technologies, ref. 12.0 GA4471A) and imaged
using GenePixPro (Axon Instruments). To remove diﬀer-
ences in probe intensity between chips we used quantile
normalization (29), and the bias was removed eﬀectively.
Median pixel intensity values were background subtracted
and log-transformed. To compare the miRNA expression
levels on each tRNA substitution versus wild-type
tRNASer, we performed the moderated t-test (30) imple-
mented in the Bioconductor LIMMA Library software
(www.bioconductor.org/limma), and the P-values were
adjusted following the Benjamini–Yekutieli procedure
(31). Statistically signiﬁcant changes in miRNA expression
in cells transfected with tRNASer(Lys), tRNASer(His) or
tRNASer(Ile) compared to wild-type tRNASer-transfected
cells were determined (P-value threshold< 0.05). There is
no signiﬁcant variation in miRNA expression between
non-transfected Hek293 cells and the same cells
trasnfected with wild-type RNASer.
RESULTS
Design of a battery of mutagenic tRNAs
To construct the mutagenic tRNAs used in this study, we
took advantage of the recognition mechanism between
seryl-tRNA synthetase (SRS) and its cognate substrate
tRNASer. Unlike most other cases, the speciﬁc recognition
of tRNASer by SRS does not depend on the sequence of
the anticodon of the tRNA (32,33). Thus, it is possible to
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modify the decoding sequence (the anticodon) of tRNASer
without interfering with its capacity to be serylated (33)
(Figure 1a). The result of such a modiﬁcation is a chimeric
tRNA that will be readily aminoacylated with serine by
SRS, but will be utilized by the ribosome to translate
codons complementary to the engineered anticodon,
thus generating ‘X’ to S mutations randomly in the
proteome.
We constructed a battery of engineered tRNASer that
could be expressed and were active in human cells, and in
a chick embryo neural system, after transfection with a
plasmid carrying a gene coding for the modiﬁed
tRNASer (Supplementary Figure S1). We initially con-
structed 17 tRNA variants designed to cause all possible
X-S mutations with exception of W-S and M-S
(Supplementary Table S1). We tested all the tRNAs for
their ability to restore ﬂuorescence of a reporter GFP
coded by a gene where the essential residue serine-65
(S65) had been substituted for each of the 18 codons
recognized by our engineered tRNAs. Ten out of the
eighteen tRNAs could be shown to cause an increase in
GFP ﬂuorescence in cells expressing the corresponding
GFP variant (Supplementary Figure S2).
In order to evaluate the relative impact of the mutagenic
tRNAs in the cell, we constructed a new GFP variant that
did not contain any of the codons being mutated by our
tRNAs. In this way, cell ﬂuorescence could be used as an
indirect measure of the eﬀect of each tRNA variant. Since
tryptophan and methionine only use one codon, we could
not use this strategy to evaluate tRNAs causing W-S, or
M-S mutations. In cells containing this reporter GFP
protein, and transfected with our battery of tRNAs,
reductions of ﬂuorescence ranging from 4 to 85%
depending on the tRNA chimera used were seen
(Figure 1b). Based on these initial results chimeric
tRNAs harbouring anticodons decoding isoleucine
[tRNASer(Ile)], histidine [tRNASer(His)] and lysine
[tRNASer(Lys)], were chosen as representatives of, respec-
tively, high, medium and low eﬀect constructs and used
for all further studies.
We performed amino acid quantitative analysis to
conﬁrm the introduction of amino acid substitutions in
the proteome. We used two diﬀerent proteins as markers
to quantify the misincorporation eﬃciency of the chimeric
tRNAs. One of the proteins was cytosolic GFP, and the
second was human epidermal growth factor receptor
(EGFR), which undergoes obligatory ER transit.
Strikingly, amino acid analyses of puriﬁed GFP and
EGFR from cells transfected with tRNASer(Lys),
tRNASer(His) and tRNASer(Ile) showed that all the
mutable residues had been replaced by serine (Table 1).
Thus, our method is extraordinarily eﬃcient at the intro-
duction of mutations in the proteome. This is most likely
due to the high cytosolic concentrations reached by the
engineered tRNAs. These results, and the statistical
analysis performed later (see below), show that all our
tRNAs are equally active and eﬃciently used by the
ribosome.
Eﬀects upon cell physiology and growth of
mutagenic tRNAs
We evaluated the eﬀects of the chimeric tRNAs upon
general cell parameters such as transcription, protein syn-
thesis levels, growth rate, and cell viability. GFP mRNA
levels were found to be equal in all transfected cells, but
GFP levels varied in correlation with the measured ﬂuo-
rescence (Figure 2a). Thus, as expected, the eﬀect of
chimeric tRNAs occurs at the level of gene translation.
Incorporation of L-azidohomoalanine (a labelled deri-
vate of methionine) conﬁrmed that the observed
down-regulation of translation aﬀected the entire
proteome in the same linear manner (Figure 2b).
We then studied the eﬀect of the mutagenic tRNAs
upon cell viability and growth, both in mammalian cells
and in chick embryos (28). The eﬀect of the three chimeric
tRNAs in the human cell line was again linear, and
correlated with their relative eﬀect upon protein synthesis.
In agreement with our previous observations, chimeric
tRNASer(Ile) caused the strongest inhibition of cell
Figure 1. Chimeric tRNA as adaptors to mistranslate speciﬁc codons.
(a) Schematic ﬁgure of chimeric tRNA concept: chimeric tRNAs are
engineered by substituting the wild-type anticodon in tRNASer to
speciﬁc triplets coding for other amino acids. The chimeric tRNASer
will only be charged with serine by seryl-tRNA-synthetase, no matter
what the anticodon sequence is. Therefore, expression of chimeric
tRNASer will produce mistranslated proteins. (b) GFP ﬂuorescence
was used as a marker to measure the impact of chimeric tRNA expres-
sion on the cell. Fluorescence was analysed by ﬂow cytometry.
A histogram depicting the diﬀerent eﬀect of each chimeric tRNA is
shown. Mean values+ standard deviations from three independent
transfections are given.
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division in vitro (Figure 2c) and was active in vivo (Figure
2d). Similarly, the three tRNAs caused increasing levels of
cell death in human cells (Figure 2e), and tRNASer(Ile)
caused the strongest apoptosis induction in chick
embryos 6 h after electroporation (Figure 2f).
Statistical analysis of the physiological eﬀects caused
by the mutagenic tRNAs
To further characterize our approach, we wanted to
compare the observed eﬀects of our tRNAs with the
expected impact of each engineered mutation. We
reasoned that the impact of each mutation would
depend on the frequency of the mutated codon and on
the nature of the amino acid substitution. If all the
tRNAs used are functionally equal, values in sequence
substitution matrices (PAM or BLOSUM, for instance)
should correlate with the intensity of the eﬀect of each
mutagenic tRNA. Equally, the impact of the tRNAs
should correlate with the frequency of the mutated
codons in the genome.
To verify these hypotheses, we analysed the correlation
of these two parameters (substitution likelihood and
codon frequency) with the decrease in ﬂuorescence
caused by the ten tRNA chimeras. The substitution
likelihood values were obtained from the substitution
matrix Blosum62 (34). The GenBank database was used
to calculate the frequency of the mutated codons in the
human genome and in genes coding for proteins
associated with the ER, nucleus, mitochondria and
cytosol (35–37).
As expected, a signiﬁcant correlation was found
between the eﬀects of the chimeric tRNAs and the substi-
tution values for their respective mutations determined by
the Blosum62 matrix (Figure 3a). This is evidence that all
the tRNA variants are equally active in the cell, and that
the relative eﬀects that they cause are determined
predominantly by the nature of the mutation that they
generate.
We then compared the eﬀect of the tRNAs tested
with frequencies of their respective codons in the whole
human genome. Surprisingly, ﬂuorescence variation
was not associated with genome-wide codon frequencies.
We then identiﬁed genes coding for ER-, mitochondria-,
nucleus- and cytoplasm-associated proteins. No signiﬁ-
cant association was found with cytoplasm- and
nucleus-related genes, but a signiﬁcant association was
found with genes coding for ER- and mitochondria-
targeted proteins. Importantly, these correlations are not
caused by an over-representation in the ER of codons
recognized by high-eﬀect chimeric tRNAs, or by diﬀer-
ences in the overall number of substitutions expected for
each section of the proteome (Supplementary Table S2).
In a multivariate analysis of our data that compared
codon frequencies and Blosum62 substitution values
with ﬂuorescence values a signiﬁcant correlation was
found only between the decrease in ﬂuorescence caused
by our tRNAs and the codon composition of
ER-associated family of proteins (Figure 3b). Thus, the
statistical analysis performed show that our tRNAs
cause eﬀects that correlate with the nature of the substi-
tution that they generate. Moreover, in human Hek293
cells the eﬀect of the tRNAs correlates better with the
codon composition of ER-associated genes, indicating
that the ER may be the principal agent of the cellular
reaction to the mutagenic stress caused by the mutations
in this cell type.
Induction of the unfolded protein response
We tested the activation of UPR caused by the chimeric
tRNAs in our two experimental models. In cells
expressing the chimeric tRNAs, a linear increment in
activated forms of UPR components was observed.
Figure 4a shows the activation of BiP and transcription
factor CHOP in human cells after transfection with
tRNASer(Lys), tRNASer(His) and tRNASer(Ile). Figure
4b shows the activation of Xbp-1 and ATF6, and
phosphorylation of eIF2-a. Thus, chimeric tRNAs
Table 1. Amino acid quantitative analyses of reporter proteins EGFR (synthesized in ER-bound ribosomes) and GFP (synthesized in cytosolic
ribosomes)
Number of codons
theoretically targeted
Decrease of targeted
amino acid
Number of original
serine residues
Increment in
serine residues
EGFR (ER transit)
tRNASer Lys 35 34.9 84 34.9
tRNASer His 11 11 84 11
tRNASer Ile 17 16.73 84 17.9
GFP (no ER transit)
tRNASer Lys 19 19 16 18.7
tRNASer His 2 2 16 2
tRNASer Ile 5 4.96 16 5.81
‘Codons theoretically targeted’ refers to the total number of codons complementary to the anticodon of each chimeric tRNA. ‘Decrease of targeted
amino acid’ values are obtained by subtracting the experimentally determined number of each of the amino acids whose codons are targeted by the
three chimeric tRNAs (Lys, His and Ile) from the total number of the same residue expected from the gene sequence.
Similarly, the ‘Number of original serine residues’ refers to the number of serines expected in the protein from the gene sequence, while ‘increment in
serine residues’ refers to the increment of serine residues experimentally determined in the reporter proteins after transfection with each chimeric
tRNA. Close coincidence between the values in columns ‘Decrease of targeted amino acid’ and ‘Increment in serine residues’ indicates that chimeric
tRNAs cause a complete substitution in their targeted codons after transfection.
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Figure 2. General physiological eﬀects of chimeric tRNAs in vitro and in vivo. (a) Semi-quantitative RT–PCR of wt GFP mRNA shows that
transcription is not aﬀected by the expression of chimeric tRNAs. RPL19 mRNA was used as a control. Immunoblotting with an a-GFP
antibody shows that GFP synthesis is reduced proportionally to the reduction observed in cell ﬂuorescence (Figure 1b). b-Tubulin was used as a
control. Error bars represent standard deviations from ﬁve independent experiments. (b) Total protein synthesis analysed by pulse-label experiments
shows a reduction in total protein production after expression of chimeric tRNAs proportionally to the reduction in cell ﬂuorescence (Figure 1b).
Controls from cells not transfected and cells transfected with wild-type tRNASer are shown. (c) Eﬀect upon cell division of the chimeric tRNAs. Cells
were counted at diﬀerent times using ﬂow cytometry. The data shows a reduction in growth rate for each tRNA that is to the reduction in cell
ﬂuorescence caused by the same molecule. (d) Eﬀect in vivo of tRNASer(Ile) upon cell division. BrdU incorporation was measured in vivo in chicken
embryos electroporated with chimeric tRNASer(Ile). A signiﬁcant decrease in BrdU incorporation was observed in transfected embryos, indicating
that the expression of chimeric tRNAs blocks cell proliferation during neural tube development. (e) Cell death and apoptosis measured in cultures
transfected with chimeric tRNAs. Apoptosis was monitored by staining with propidium iodide, and the proportion of dead cells in each culture was
measured by ﬂow cytometry. The induction of cell death and apoptosis by each of the chimeric tRNAs tested was proportional to the reduction
observed in cell ﬂuorescence for the same tRNAs. (f) Induction of apoptosis in a chick neural cells expressing tRNASer(Ile) was monitored by
caspase-3 immunostaining. Sections from electroporated embryos were stained with an a-caspase-3 antibody (6, 12 and 18 h after electroporation)
and the number of labelled cells was quantiﬁed. A signiﬁcant increase of caspase-3-positive cells is detected. The white arrow indicates the
electroporated side of the embryo. GFP shows transfected cells. Data are means+SD (graph).
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Figure 3. Statistical analysis. (a) Univariate analysis between the eﬀect of each of the 10 tRNAs tested (in ﬂuorescence values) and BLOSUM62
matrix substitution values, genome-wide codon frequency and, ER-, mitochondria-, nucleus- and cytoplasm-codon frequencies in related genes. The
P-values for statistical signiﬁcance are shown. BLOSUM62 matrix values were signiﬁcantly associated with ﬂuorescence. A signiﬁcant association was
also found for the ER- and mitochondria-related genes. No signiﬁcant association was found for the cytoplasm and nucleus protein families.
(b) Multivariate analysis graph. Fluorescence versus BLOSUM62 score and ER codon frequencies (P=0.012) are represented. Fluorescence
values determined for each of the ten mutagenic tRNAs are plotted against the frequency of the codons recognized by the same tRNAs in
ER-related genes. For each tRNA the results of ﬁve independent transfections are shown. In this analysis, only the ER codon population statistically
correlates with the proﬁle of diﬀerential eﬀects. The P-values calculated for the comparison with genome-wide, cytoplasmic, mitochondrial and
nuclear codon frequencies are shown.
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activate all the major components of the UPR. Moreover,
in all cases the relative increases caused by the diﬀerent
mutating tRNAs are linear, and the activation of the
response takes place between 10 and 24 h after
transfection. In all cases, the relative increases caused by
the diﬀerent mutating tRNAs are equivalent, and the
activation of the response takes place between 10 and
24 h after transfection.
To obtain a second experimental reference, we moni-
tored the activation of the UPR in a chicken embryo
model. Figure 4c shows the time-dependent activation of
BiP in the neural system of chick embryos electroporated
Figure 4. Activation of UPR by chimeric tRNAs. (a) Kinetics of BIP and CHOP with persistent ER stress in vitro. Semi-quantitative RT–PCR
(SQ-RT–PCR) was performed to check BIP and CHOP mRNA levels at the indicated diﬀerent time points. (b) Activation of Xbp-1 and ATF6, and
phosphorylation of eIF2a in cells expressing chimeric tRNAs. The presence of full-length (u) and spliced (s) Xbp-1 forms was checked by PCR.
(c) BiP transcription induction in vivo. The expression levels of BiP (black staining) induced by each chimeric tRNA in a chicken embryo are
proportional to the decrease in wt GFP ﬂuorescence caused by the same tRNAs. Images are representative of three independent experiments 6 h
post-electroporation (PE). GFP signal indicates the co-electroporated cells.
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with the three chimeric tRNAs. BiP was activated
diﬀerentially by the three diﬀerent tRNAs 6 h after
electroporation. The activation pattern found is equiva-
lent to the response detected in human cells.
Together, our results show that the UPR is reactive to
the accumulation of translation errors in the proteome
caused by the mutagenic tRNAs. The mutations caused
by the tRNA chimeras promptly induce an activation that
is linear and depending on the nature of the mutations
being introduced. This responsiveness of the ER is
coherent with the statistical correlation found between
the eﬀects of the tRNAs and the codon composition of
ER-associated genes.
We also tested whether components of the heat-shock
response and UPS were activated by monitoring levels of
HSP72 and ubiquitin in the same cell type and in chicken
embryos. As expected, ubiquitin and HSP72 levels
increased signiﬁcantly in both systems (Supplementary
Figure S3). The activation of ubiquitin and HSP72 was
intense, but equal for all tRNAs. Both components were
activated later and uniformly by the three chimeric tRNAs
(Supplementary Figure S3).
Thus, our method readily activates the two main stress
responses known in eukaryotic cells. We could detect a
linear activation of the UPR depending on the mutation
being introduced, which may indicate a role of the UPR in
the early response to proteome damage. We reasoned that
we could take advantage of that response proﬁle of the
UPR to identify new UPR-related factors that may be
induced with a similar pattern.
Identiﬁcation of microRNA families responsive to
proteome stress
Having observed that, in Hek293 cells, the components of
the UPR reacted proportionally to the extent of proteome
stress induced by our tRNAs we decided to use this
response pattern to identify miRNAs that might be
repressed or expressed as a consequence of the induced
proteome stress. microRNAs (miRNAs) are small
non-coding RNAs that post-transcriptionally regulate
gene expression (38,39). They have been implicated in a
number of biological processes (40,41) and have been
recently emerged as important regulators of translation
and cell stress responses (42,43).
Total RNA was isolated from Hek293 cells transfected
with the chimeric tRNAs (tRNASer(Lys), tRNASer(His),
tRNASer(Ile) and the control wild-type tRNASer). Five
micrograms of labelled RNA puriﬁed from each
transfected culture were hybridized to a microRNA
array with 866 human miRNAs. We proﬁled global
miRNA expression in Hek293 cells transfected with the
chimeric tRNAs and we compared the miRNA diﬀerential
expression with cells transfected with wild-type tRNASer.
Importantly, no variation in miRNA expression signature
was found between non-transfected Hek293 cells and the
same cells after transfection with wild-type tRNASer.
The eﬀect of the three chimeric tRNAs upon the
microRNA population of transfected cells was identical
to that observed for UPR components. A graded change
in the concentration of speciﬁc miRNAs was seen,
with the strongest eﬀect being caused by tRNASer(Ile).
Thus, expression of tRNASer(Lys), tRNASer(His) and
tRNASer(Ile), respectively, induced 3, 131 and 205, and
repressed 2, 22 and 43 miRNAs (Figure 5a). Although
the number of miRNAs being aﬀected by tRNASer(Lys)
was modest, those identiﬁed were also aﬀected by
tRNASer(His) and tRNASer(Ile), and their relative
change in concentration was signiﬁcant and proportional
to the physiological eﬀects of the same tRNAs (Figure 5b).
DISCUSSION
The identiﬁcation of all the components of cellular stress
responses and the elucidation of the functional and spatial
connections between these pathways will require the appli-
cation of diﬀerent experimental approaches to induce
proteome stress. We have implemented a controlled
proteome-wide mutagenesis system through the use of
engineered tRNAs that induces unfolded protein stress
responses. This system is based in the recognition charac-
teristics between tRNASer and SRS, and allows for the
introduction of at least ten diﬀerent ‘X to S’ substitutions
throughout the proteome. Strikingly, amino acid analysis
of proteins isolated from cells transfected with chimeric
tRNASSer(Ile) indicate a complete substitution of the
isoleucine residues coded by the targeted codon by serine
in two diﬀerent reporter proteins.
This substitution eﬃciency is likely due to the high
expression of the tRNAs transfected, which can be
detected in the cell up to ﬁve days after transfection
(Supplementary Figure S1d). It is likely that chimeric
tRNA levels could be experimentally regulated through
Figure 5. Microarray screen identiﬁes miRNAs linked to UPR induc-
tion. Up- and down-regulated miRNAs populations in cells transfected
with the mutagenic tRNAs. Number of miRNAs activated or repressed
in cells transfected with tRNASer(Lys), tRNASer(His), tRNASer(Ile),
compared with cells transfected with wild-type tRNASer. Graded acti-
vation and repression of miRNAs can be observed.
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modiﬁcations of their gene context or transfection condi-
tions. It should also be noticed that the recognition of
tRNAAla by alanyl-tRNA synthetase, or of tRNALeu by
leucyl-tRNA synthetase, are also insensitive to the
anticodon sequences of the tRNAs and could be used in
a similar way to increase the range of mutations that can
be introduced in the proteome (44–47).
Both in human cells and in chicken, the mutagenic eﬀect
of chimeric tRNAs elicits a response 6 h after transfection,
which increases progressively up to 72 h. Interestingly, not
all the stress pathways respond identically. Our results
indicate that the proteasome-ubiquitin system responds
to our set of mutagenic tRNAs uniformly, whereas the
UPR reacts proportionally to the severity of the errors
being accumulated in the whole proteome. Similarly, the
UPS reaction is slower than the activation of the unfolded
protein response. This late activation of the UPS may
reﬂect a late onset of ERAD in our experimental
models. Although the reasons for this diﬀerential activa-
tion of UPR and UPS are not clear they suggest that
modiﬁcations in the method (for instance down regulating
the levels of tRNAs) may allow for the diﬀerential activa-
tion of diﬀerent stress responses.
As we have shown, the response proﬁle that our
approach generates can be useful in the identiﬁcation of
potential interactions or components of the induced stress
pathways. Our approach can be applied to any cell type or
organism susceptible of transfection. The extreme conser-
vation of components of the translation apparatus facili-
tates the utilization of human tRNAs in other vertebrate
systems, as seen in this work. Variations in the response to
the stress caused by mutagenic tRNAs among diﬀerent
cell types could help identify the reasons behind the idio-
syncratic sensitivities to proteome damage of diﬀerent
tissues, and may help explain why certain organs appear
to be particularly susceptible to damage caused by protein
aggregation.
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